Showing results (171-180 of 234) with videos related to

Sort By:
Pageof 24
Critical Reviews in Oncology/Hematology|November 17, 2019
Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysisFausto Petrelli, Agostina De Stefani, Francesca Trevisan, et al.
European Journal of Clinical Investigation|January 20, 2021
Effects of hypertension on cancer survival: A meta-analysisFausto Petrelli, Antonio Ghidini, Mary Cabiddu, et al.
Critical Reviews in Oncology/Hematology|March 21, 2007
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panelCesare Gridelli, Matti S Aapro, Sandro Barni, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysisFausto Petrelli, Rosa Berenato, Luca Turati, et al.
Panminerva Medica|February 2, 2021
The core components of cardio-oncology rehabilitationElio Venturini, Susan Gilchrist, Elisabetta Corsi, et al.
The Lancet. Oncology|September 4, 2009
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind studyGiancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, et al.
The Oncologist|August 14, 2013
Dose-dense FEC followed by dose-dense ixabepilone as neoadjuvant treatment for breast cancer patients: a feasibility studyMatteo Clavarezza, Roberto Bordonaro, Bruno Daniele, et al.
JAMA Network Open|March 29, 2021
Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysisFausto Petrelli, Alessio Cortellini, Alice Indini, et al.
Clinical Colorectal Cancer|April 12, 2015
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II StudyNicola Personeni, Lorenza Rimassa, Claudio Verusio, et al.
The Lancet. Oncology|December 14, 2007
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trialStefano Cascinu, Rossana Berardi, Roberto Labianca, et al.
Pageof 24